000284754 001__ 284754
000284754 005__ 20240229155055.0
000284754 0247_ $$2doi$$a10.3390/cancers15194877
000284754 0247_ $$2pmid$$apmid:37835571
000284754 0247_ $$2pmc$$apmc:PMC10571892
000284754 0247_ $$2altmetric$$aaltmetric:155209437
000284754 037__ $$aDKFZ-2023-02065
000284754 041__ $$aEnglish
000284754 082__ $$a610
000284754 1001_ $$aCiobanu-Caraus, Olga$$b0
000284754 245__ $$aThe Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups.
000284754 260__ $$aBasel$$bMDPI$$c2023
000284754 3367_ $$2DRIVER$$aarticle
000284754 3367_ $$2DataCite$$aOutput Types/Journal article
000284754 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1697448605_4179
000284754 3367_ $$2BibTeX$$aARTICLE
000284754 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000284754 3367_ $$00$$2EndNote$$aJournal Article
000284754 520__ $$aDevelopmental gene expression data from medulloblastoma (MB) suggest that WNT-MB originates from the region of the embryonic lower rhombic lip (LRL), whereas SHH-MB and non-WNT/non-SHH MB arise from cerebellar precursor matrix regions. This study aimed to analyze detailed intraoperative data with regard to the site of origin (STO) and compare these findings with the hypothesized regions of origin associated with the molecular group. A review of the institutional database identified 58 out of 72 pediatric patients who were operated for an MB at our department between 1996 and 2020 that had a detailed operative report and a surgical video as well as clinical and genetic classification data available for analysis. The STO was assessed based on intraoperative findings. Using the intraoperatively defined STO, 'correct' prediction of molecular groups was feasible in 20% of WNT-MB, 60% of SHH-MB and 71% of non-WNT/non-SHH MB. The positive predictive values of the neurosurgical inspection to detect the molecular group were 0.21 (95% CI 0.08-0.48) for WNT-MB, 0.86 (95% CI 0.49-0.97) for SHH-MB and 0.73 (95% CI 0.57-0.85) for non-WNT/non-SHH MB. The present study demonstrated a limited predictive value of the intraoperatively observed STO for the prediction of the molecular group of MB.
000284754 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000284754 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000284754 650_7 $$2Other$$aMB
000284754 650_7 $$2Other$$amolecular group
000284754 650_7 $$2Other$$aneurosurgery
000284754 650_7 $$2Other$$aorigin
000284754 7001_ $$00000-0001-8112-2795$$aCzech, Thomas$$b1
000284754 7001_ $$00000-0002-5736-8231$$aPeyrl, Andreas$$b2
000284754 7001_ $$00000-0003-1016-0545$$aHaberler, Christine$$b3
000284754 7001_ $$aKasprian, Gregor$$b4
000284754 7001_ $$aFurtner, Julia$$b5
000284754 7001_ $$0P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aKool, Marcel$$b6$$udkfz
000284754 7001_ $$0P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b$$aSill, Martin$$b7$$udkfz
000284754 7001_ $$aFrischer, Josa M$$b8
000284754 7001_ $$00000-0002-5211-382X$$aCho, Anna$$b9
000284754 7001_ $$00000-0002-9419-6790$$aSlavc, Irene$$b10
000284754 7001_ $$00000-0002-9249-8082$$aRössler, Karl$$b11
000284754 7001_ $$aGojo, Johannes$$b12
000284754 7001_ $$00000-0002-1843-7732$$aDorfer, Christian$$b13
000284754 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers15194877$$gVol. 15, no. 19, p. 4877 -$$n19$$p4877$$tCancers$$v15$$x2072-6694$$y2023
000284754 909CO $$ooai:inrepo02.dkfz.de:284754$$pVDB
000284754 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000284754 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000284754 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000284754 9141_ $$y2023
000284754 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-07-31T16:07:06Z
000284754 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-07-31T16:07:06Z
000284754 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-07-31T16:07:06Z
000284754 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2023-07-31T16:07:06Z
000284754 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-29
000284754 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-08-29
000284754 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-29
000284754 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-08-29
000284754 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-08-29
000284754 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2022$$d2023-10-26
000284754 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-26
000284754 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-26
000284754 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-26
000284754 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-26
000284754 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-26
000284754 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-26
000284754 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-26
000284754 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-26
000284754 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2022$$d2023-10-26
000284754 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000284754 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000284754 980__ $$ajournal
000284754 980__ $$aVDB
000284754 980__ $$aI:(DE-He78)B062-20160331
000284754 980__ $$aI:(DE-He78)HD01-20160331
000284754 980__ $$aUNRESTRICTED